Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Exon skipping therapy for Duchenne muscular dystrophy: outcome of preclinical study and prospective for clinical study].

No to hattatsu = Brain and development - 1 Mar 2010

Nakamura A, Takeda S

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dystrophin
Share to Exons
Share to Muscular Dystrophy, Duchenne
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Treatment Outcome

Source

Identifiers

PMID: 23858595

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Exon skipping therapy for Duchenne muscular dystrophy: outcome of preclinical study and prospective for clinical study].PMID 23858595Read ↗

Duchenne muscular dystrophy: Current treatment and emerging exon skipping and gene therapy approachSemantic proximity Read ↗

Current Outline of Exon Skipping Trials in Duchenne Muscular DystrophySemantic proximity Read ↗

Exon-Skipping Therapy: A Roadblock, Detour, or Bump in the Road?Semantic proximity Read ↗

Exon-Skipping in Duchenne Muscular Dystrophy.Semantic proximity Read ↗

[Molecular therapy for duchenne muscular dystrophy].Semantic proximity Read ↗

Exon skipping: a first in class strategy for Duchenne muscular dystrophySemantic proximity Read ↗

194th ENMC international workshop. 3rd ENMC workshop on exon skipping: Towards clinical application of antisense-mediated exon skipping for Duchenne muscular dystrophy 8–10 December 2012, Naarden, The NetherlandsSemantic proximity Read ↗

[Antisense oligos for muscular dystrophy].Semantic proximity Read ↗

Therapeutic approaches for Duchenne muscular dystrophy.Semantic proximity Read ↗

Moving towards successful exon-skipping therapy for Duchenne muscular dystrophy.Semantic proximity Read ↗

Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and ChallengesSemantic proximity Read ↗

Restoring Protein Expression in Neuromuscular Conditions: A Review Assessing the Current State of Exon Skipping/Inclusion and Gene Therapies for Duchenne Muscular Dystrophy and Spinal Muscular AtrophySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.